InMode Ltd. (INMD)
| Market Cap | 2.01B |
| Revenue (ttm) | 377.96M |
| Net Income (ttm) | 169.30M |
| Shares Out | 83.08M |
| EPS (ttm) | 1.97 |
| PE Ratio | 12.27 |
| Forward PE | 10.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,234,568 |
| Open | 23.31 |
| Previous Close | 22.82 |
| Day's Range | 22.88 - 24.14 |
| 52-Week Range | 20.60 - 99.27 |
| Beta | 2.12 |
| Analysts | Buy |
| Price Target | 56.10 (+132.4%) |
| Earnings Date | Jul 27, 2022 |
About INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also des... [Read more...]
Financial Performance
In 2021, InMode's revenue was $357.57 million, an increase of 73.49% compared to the previous year's $206.11 million. Earnings were $164.97 million, an increase of 119.87%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for INMD stock is "Buy." The 12-month stock price forecast is 56.1, which is an increase of 132.39% from the latest price.
News
Here's My Top Value Stock to Buy Right Now
Its shares are dirt cheap, but the business is growing fast.
InMode Receives Health Canada Certification of EmpowerRF Women's Wellness Technology
IRVINE, Calif. , June 15, 2022 /PRNewswire/ -- InMode Ltd.
This Growth Stock Could 10X in 10 Years
It'll need to keep eating into its competitors' market share all the while.
InMode to Participate at the UBS Healthcare One-on-One Virtual Day
YOKNEAM, Israel , May 23, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and ...
1 Company Disrupting Plastic Surgery, Not Patients
InMode's sales and profits have boomed, but you wouldn't know it from the company's share price.
This Is Why InMode Stock Fell 32% in April
The financial results are solid but investors are still lowering their expectations.
InMode Reports First Quarter 2022 Financial Results:
Quarterly Revenue of $85.9M, GAAP Net Income of $31M Represent 31% and 16% Year-Over-Year Growth, Respectively YOKNEAM, Israel, May 2, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leadi...
3 Growth Stocks That Will Beat Cathie Wood's Ark Innovation ETF This Year
These three companies are growing rapidly. These growth stocks should easily perform better than Cathie Wood's ETFs this year.
InMode Expects First Quarter 2022 Revenue Between $85.0-$85.5M, Non-GAAP Earnings per Diluted Share Between $0.38-$0.39
Conference call to be held on Monday, May 2, 2022, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 11, 2022 /PRNewswire/ -- InMode Ltd.
3 Under-the-Radar Biotech Stocks That Will Zoom Higher
Finding stocks with significant upside before the rest of the market sees what's happening can be highly profitable.
InMode to Participate Virtually in a Fireside Chat at the 21st Annual Needham Healthcare Conference
YOKNEAM, Israel, April 5, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate virtually in a f...
3 Unstoppable Growth Stocks to Buy in a Stock Market Sell-Off
2022 has been unpredictable thus far, but these companies are likely to shine in the long run.
InMode Announces Share Repurchase Program of Up to 1 Million Shares
YOKNEAM, Israel, March 10, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced that its Board of Directors has appro...
InMode to Participate in Investor Conferences in March
YOKNEAM, Israel, March 2, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in the following...
InMode Reports Record Fourth Quarter and Full Year 2021 Financial Results:
YOKNEAM, Israel, Feb. 10, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for...
3 Top Healthcare Stocks to Buy for February
Whether you're looking for growth or big dividends, the healthcare sector's got deals galore.
Buy This Unstoppable Growth Stock Instead of NFTs in 2022
It doesn't need to be part of a speculative bubble to grow in value.
Is It Too Late to Buy InMode Stock?
Not even a little bit.
InMode Expects Record Fourth Quarter & Full Year 2021 Financial Results, Q4 Revenue Between $109.5M-$110M
YOKNEAM, Israel, Jan. 12, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ), a leading global provider of innovative medical technologies, announced today that it expects to release its financial result...
Here's Why InMode Stock Was Up 197% Last Year
Business is booming for this medical device company.
InMode Is Bringing a Paradigm Shift to Cosmetic Procedures
Traditional cosmetic surgery is expensive, invasive, and can be quite risky. This highly profitable company changes all of that.
InMode to Present at the 24th Needham Virtual Growth Conference
YOKNEAM, Israel, Jan. 3, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chairman and Chief Executive O...
A 10-Bagger in 2 Years? What You Need to Know About This Medical Device Stock
We've never seen margins this consistently high.